Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents?

Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents?

Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Serge Jabbour, MD, FACP, FACE

Serge Jabbour, MD, FACP, FACE

Professor of Medicine Thomas Jefferson University Division of Endocrinology, Diabetes and Metabolic Diseases Department of Medicine Jefferson Medical College Philadelphia, Pennsylvania